These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 12893968

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
    Hayashi YK, Ogawa M, Tagawa K, Noguchi S, Ishihara T, Nonaka I, Arahata K.
    Neurology; 2001 Jul 10; 57(1):115-21. PubMed ID: 11445638
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.
    Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H, Straub V, Mathews KD, Moore SA, Campbell KP.
    Nature; 2002 Jul 25; 418(6896):417-22. PubMed ID: 12140558
    [Abstract] [Full Text] [Related]

  • 9. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.
    Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA, Ponting CP, Estournet B, Romero NB, Mercuri E, Voit T, Sewry CA, Guicheney P, Muntoni F.
    Am J Hum Genet; 2001 Dec 25; 69(6):1198-209. PubMed ID: 11592034
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Recent Advances in α-dystroglycanopathy].
    Kuga A, Kanagawa M, Toda T.
    Brain Nerve; 2011 Nov 25; 63(11):1189-95. PubMed ID: 22068471
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Dystroglycan linkage and muscular dystrophy].
    Shimizu T.
    Rinsho Shinkeigaku; 2002 Nov 25; 42(11):1091-4. PubMed ID: 12784674
    [Abstract] [Full Text] [Related]

  • 17. Functions of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in neuromuscular system and other somatic organs.
    Yamamoto T, Shibata N, Saito Y, Osawa M, Kobayashi M.
    Cent Nerv Syst Agents Med Chem; 2010 Jun 01; 10(2):169-79. PubMed ID: 20518731
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of alpha-dystroglycan.
    Xiong H, Kobayashi K, Tachikawa M, Manya H, Takeda S, Chiyonobu T, Fujikake N, Wang F, Nishimoto A, Morris GE, Nagai Y, Kanagawa M, Endo T, Toda T.
    Biochem Biophys Res Commun; 2006 Dec 01; 350(4):935-41. PubMed ID: 17034757
    [Abstract] [Full Text] [Related]

  • 20. The role of defective glycosylation in congenital muscular dystrophy.
    Schachter H, Vajsar J, Zhang W.
    Glycoconj J; 2004 Dec 01; 20(5):291-300. PubMed ID: 15229394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.